Literature DB >> 26371286

Comment on ESMO Magnitude of Clinical Benefit Scale.

T Muhonen1, H Joensuu2, P Pfeiffer3.   

Abstract

Mesh：

Year:  2015        PMID： 26371286     DOI： 10.1093/annonc/mdv384

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules.

Authors:  Urania Dafni; Dimitris Karlis; Xanthi Pedeli; Jan Bogaerts; George Pentheroudakis; Josep Tabernero; Christoph C Zielinski; Martine J Piccart; Elisabeth G E de Vries; Nicola Jane Latino; Jean-Yves Douillard; Nathan I Cherny
Journal:  ESMO Open       Date:  2017-10-09

2.  The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation.

Authors:  Alberto Sobrero
Journal:  ESMO Open       Date:  2017-03-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.